MYLAN 351 (Haloperidol 0.5 mg)
Pill imprint MYLAN 351 has been identified as Haloperidol 0.5 mg.
Haloperidol is used in the treatment of psychosis; dementia; icu agitation; nausea/vomiting; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy. Haloperidol 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 351 (Haloperidol 0.5 mg)
- 0.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0733||UDL Laboratories Inc|
|18837-0348||Innoviant Pharmacy Inc (repackager)|
|68071-0494||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about haloperidol
- Haloperidol decanoate
- Haloperidol solution
- Haloperidol tablets
- Haloperidol (Advanced Reading)
- Haloperidol Intramuscular (Advanced Reading)